Projet The use of computational methods to design drugs – Human Brain Project Specific Grant Agreement 1 Jean-Pierre Changeux
Projet Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis (HERCULES) Benno Schwikowski
Projet Protein synthesis machinery of Trypanosomatid as a therapeutic target Nadia Izadi-Pruneyre • Sylvie Pochet
Projet Studying vulnerability to drug addiction: contribution of the nicotinic acetylcholine receptor α5 subunit. Morgane Besson
Projet Toxins and nanobodies as subtype-specific ligands and allosteric modulators of nicotinic acetylcholine receptors (PTR Nicobinder) Pierre-Jean Corringer
Projet Discovery of allosteric modulators specifically targeting α5-containing nAChRs. (ANR-Nicofive) Pierre-Jean Corringer
Projet Mutations in PDZ Binding Motif (PBM)-containing proteins associated to the Usher syndrome Nicolas Wolff
Projet DIM ELICIT – Domain of Main Interest “Empowering LIfe sCiences with Innovative Technologies” Jean-Christophe Olivo-Marin • Elodie Brient-Litzler • Patrick Tabeling
Projet ERC starting grant – CRISPAIR: Study of the interplay between CRISPR interference and DNA repair pathways towards the development of novel CRISPR tools David Bikard
Projet Conformational sampling and functional dynamics of histidine kinases Nathalie Duclert-Savatier • Thérèse Malliavin
Projet Development of inhibitors targeting the allosteric activation of adenyl cyclases Thérèse Malliavin
Projet Targeting biomechanical properties of infected red blood cells to block malaria parasite transmission
Projet Set-up a humanized mouse model for testing new Plasmodium falciparum transmission-blocking drugs
Projet ATIP-Avenir: Unravelling the role of erythrocyte deformability in Plasmodium falciparum transmission
Projet Des souris et des hommes : séjour d’observation à l’hôpital pour scientifiques Clementine Schilte